| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486597 | Vaccine | 2017 | 6 Pages |
Abstract
Participants agreed CHIMs for Shigella and ETEC vaccine development could accelerate vaccine development of a promising candidate; however, it was also appreciated that variability in the model and our limited understand of the host-pathogen interaction may yield results that could negatively impact a suitable candidate. Future workshops on CHIM are needed to ensure the optimal application of these models moving forward.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Chad K. Porter, A. Louis Bourgeois, Robert W. Frenck, Michael Prouty, Nicole Maier, Mark S. Riddle,